Not only did researchers from the U-M Rogel Cancer Center identify a new subtype of aggressive prostate cancer, but they also identified how the genetic alteration was driving cancer and how to target it with treatment. Arul M. Chinnaiyan, M.D., Ph.D., director of the Michigan Center for Translational Pathology and S.P. Hicks Professor of Pathology at Michigan Medicine, discusses the teams’ findings.
